tiprankstipranks
Mesoblast (MESO)
NASDAQ:MESO
US Market
MESO
Mesoblast
RESEARCH TOOLSreports
Want to see MESO full AI Analyst Report?

Mesoblast (MESO) Stock Forecast & Price Target

928 Followers
See the Price Targets and Ratings of:

MESO Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Mesoblast
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MESO Stock 12 Month Forecast

There Are No Analyst Ratings for MESO In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MESO Financial Forecast

MESO Earnings Forecast

Next quarter’s earnings estimate for MESO is -$0.04 with a range of -$0.07 to $0.00. The previous quarter’s EPS was -$0.31. MESO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year MESO has Performed in-line its overall industry.
Next quarter’s earnings estimate for MESO is -$0.04 with a range of -$0.07 to $0.00. The previous quarter’s EPS was -$0.31. MESO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year MESO has Performed in-line its overall industry.

MESO Sales Forecast

Next quarter’s sales forecast for MESO is $54.90M with a range of $36.00M to $91.80M. The previous quarter’s sales results were $51.43M. MESO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year MESO has Performed in-line its overall industry.
Next quarter’s sales forecast for MESO is $54.90M with a range of $36.00M to $91.80M. The previous quarter’s sales results were $51.43M. MESO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year MESO has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on MESO
Jason McCarthy
Maxim Group
Maxim Group
$35
Buy
112.64%
Upside
Reiterated
04/14/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Galmed Pharmaceuticals (NASDAQ: GLMD), Neurocrine (NASDAQ: NBIX) and Mesoblast (NASDAQ: MESO)
Piper Sandler Analyst forecast on MESO
Edward Tenthoff
Piper Sandler
Piper Sandler
$35
Buy
112.64%
Upside
Reiterated
04/10/26
Mesoblast (MESO) Gets a Buy from Piper Sandler
Cantor Fitzgerald Analyst forecast on MESO
Joshua Schimmer
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Reiterated
08/29/25
Mesoblast (MESO) Receives a Buy from Cantor Fitzgerald
Jefferies Analyst forecast on MESO
Unknown Analyst
Jefferies
Not Ranked
Jefferies
―
Hold
―
Downgraded
07/18/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on MESO
Jason McCarthy
Maxim Group
Maxim Group
$35
Buy
112.64%
Upside
Reiterated
04/14/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Galmed Pharmaceuticals (NASDAQ: GLMD), Neurocrine (NASDAQ: NBIX) and Mesoblast (NASDAQ: MESO)
Piper Sandler Analyst forecast on MESO
Edward Tenthoff
Piper Sandler
Piper Sandler
$35
Buy
112.64%
Upside
Reiterated
04/10/26
Mesoblast (MESO) Gets a Buy from Piper Sandler
Cantor Fitzgerald Analyst forecast on MESO
Joshua Schimmer
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Reiterated
08/29/25
Mesoblast (MESO) Receives a Buy from Cantor Fitzgerald
Jefferies Analyst forecast on MESO
Unknown Analyst
Jefferies
Not Ranked
Jefferies
―
Hold
―
Downgraded
07/18/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
NGNENeurogene
GHGuardant Health
ENOVEnovis
OCGNOcugen
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Mesoblast

3 Months
Jason McCarthyMaxim Group
Success Rate
7/9 ratings generated profit
78%
Average Return
+36.77%
Copying Jason McCarthy's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +36.77% per trade.
1 Year
Jason McCarthyMaxim Group
Success Rate
8/9 ratings generated profit
89%
Average Return
+31.80%
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +31.80% per trade.
2 Years
Jason McCarthyMaxim Group
Success Rate
8/9 ratings generated profit
89%
Average Return
+34.10%
Copying Jason McCarthy's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +34.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MESO Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
2
4
4
2
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
4
4
2
0
In the current month, MESO has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MESO average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

MESO Stock Forecast FAQ

What is MESO’s average 12-month price target, according to analysts?
Currently, no data Available
What is MESO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MESO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is MESO a Buy, Sell or Hold?
      Currently, no data Available
      What is Mesoblast’s price target?
      Currently, no data Available
      What do analysts say about Mesoblast?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of MESO?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.